Brooks Macdonald Group PLC

Brooks Macdonald maintains a fully diluted share count of 15,877,209, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

The company's profitability and returns are not directly quantifiable due to the lack of valuation snapshot data. However, as an investment management firm, its performance is typically measured by assets under management (AUM), fee income, and net inflows, which are not provided in the current dataset.

Geographic and segment exposure is not explicitly detailed in the available data, but as a UK-based firm, Brooks Macdonald is likely concentrated in the UK market, with potential exposure to European and global markets through its investment products.

The company's growth trajectory is not quantified in the current dataset, but the investment management industry is generally influenced by macroeconomic conditions, interest rates, and investor sentiment. Analysts have provided a mean price target of 1,991.43 GBP, with a median of 1,900.00 GBP, suggesting a generally positive outlook.

Risk factors include the inability to assess liquidity risk and the potential for regulatory changes in the financial services sector. The company's dilution risk is currently low, as there is no evidence of dilutive instruments or recent equity issuance.

Recent events, such as filings or transcripts, are not detailed in the current dataset. However, the company's financial health and strategic direction would be influenced by its ability to manage AUM, attract new clients, and navigate regulatory changes in the UK and EU.

Analysts project 41.2% upside to a mean price target of 1,991 pence, reflecting strong market confidence in future performance.

Net income surged 225% year-over-year to £20.98 million, demonstrating significant profitability improvement in the latest fiscal period.

Total assets grew 19.5% year-over-year to £230.68 million, indicating substantial balance sheet expansion and operational scale.

Revenue increased 4.6% year-over-year to £111.56 million, showing top-line growth despite a negative four-year compound annual growth rate.

Dilution risk is assessed as low, suggesting minimal threat to existing shareholder value from potential equity issuance.

Long-term debt nearly quadrupled to £14.92 million, significantly increasing leverage and financial risk compared to prior periods.

Revenue declined at a 1.4% compound annual growth rate over four years, indicating a long-term structural downtrend.

Equity growth slowed to just 1.4% year-over-year, suggesting limited capital accumulation relative to asset expansion.